Precision Biosciences Stock Technical Analysis

DTIL Stock  USD 3.99  0.03  0.76%   
As of the 30th of January, Precision BioSciences holds the Variance of 20.65, risk adjusted performance of (0.10), and Coefficient Of Variation of (663.75). Precision BioSciences technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Precision BioSciences market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Precision BioSciences is priced some-what accurately, providing market reflects its current price of 3.99 per share. Given that Precision BioSciences has information ratio of (0.16), we recommend you to check out Precision BioSciences's recent market performance to make sure the company can sustain itself at a future point.

Precision BioSciences Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Precision, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PrecisionPrecision BioSciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Precision BioSciences Analyst Consensus

Target PriceAdvice# of Analysts
32.5Strong Buy4Odds
Precision BioSciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Precision analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Precision stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Precision BioSciences, talking to its executives and customers, or listening to Precision conference calls.
Precision Analyst Advice Details
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(8.96)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.45)
Return On Equity
(2.05)
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Precision BioSciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Precision BioSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Precision BioSciences.
0.00
11/01/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/30/2026
0.00
If you would invest  0.00  in Precision BioSciences on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Precision BioSciences or generate 0.0% return on investment in Precision BioSciences over 90 days. Precision BioSciences is related to or competes with Metagenomi Common, Alx Oncology, Artiva Biotherapeutics, Sutro Biopharma, Fractyl Health, Repare Therapeutics, and ATyr Pharma. Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic... More

Precision BioSciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Precision BioSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Precision BioSciences upside and downside potential and time the market with a certain degree of confidence.

Precision BioSciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Precision BioSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Precision BioSciences' standard deviation. In reality, there are many statistical measures that can use Precision BioSciences historical prices to predict the future Precision BioSciences' volatility.
Hype
Prediction
LowEstimatedHigh
0.203.998.03
Details
Intrinsic
Valuation
LowRealHigh
0.193.837.87
Details
Naive
Forecast
LowNextHigh
0.083.998.03
Details
4 Analysts
Consensus
LowTargetHigh
29.5832.5036.08
Details

Precision BioSciences January 30, 2026 Technical Indicators

Precision BioSciences Backtested Returns

Precision BioSciences maintains Sharpe Ratio (i.e., Efficiency) of -0.24, which implies the firm had a -0.24 % return per unit of risk over the last 3 months. Precision BioSciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Precision BioSciences' Risk Adjusted Performance of (0.10), variance of 20.65, and Coefficient Of Variation of (663.75) to confirm the risk estimate we provide. The company holds a Beta of 0.8, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Precision BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Precision BioSciences is expected to be smaller as well. At this point, Precision BioSciences has a negative expected return of -0.94%. Please make sure to check Precision BioSciences' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Precision BioSciences performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.87  

Very good predictability

Precision BioSciences has very good predictability. Overlapping area represents the amount of predictability between Precision BioSciences time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Precision BioSciences price movement. The serial correlation of 0.87 indicates that approximately 87.0% of current Precision BioSciences price fluctuation can be explain by its past prices.
Correlation Coefficient0.87
Spearman Rank Test0.75
Residual Average0.0
Price Variance0.05
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Precision BioSciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Precision BioSciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Precision BioSciences Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Precision BioSciences volatility developed by Welles Wilder.

About Precision BioSciences Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Precision BioSciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Precision BioSciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Precision BioSciences price pattern first instead of the macroeconomic environment surrounding Precision BioSciences. By analyzing Precision BioSciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Precision BioSciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Precision BioSciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Graham Number12.5611.17
Receivables Turnover46.5382.51

Precision BioSciences January 30, 2026 Technical Indicators

Most technical analysis of Precision help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Precision from various momentum indicators to cycle indicators. When you analyze Precision charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Precision BioSciences January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Precision stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(8.96)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.45)
Return On Equity
(2.05)
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.